T 1825/12 (Active immunisation in treating amyloidogenic disease/JANSSEN) of 24.11.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T182512.20161124
- Date of decision
- 24 November 2016
- Case number
- T 1825/12
- Petition for review of
- -
- Application number
- 06075479.3
- IPC class
- A61K 39/00A61P 25/28A61K 39/39
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Prevention and treatment of amyloidogenic disease
- Applicant name
- Janssen Alzheimer Immunotherapy
- Opponent name
- H. Lundbeck A/S
Esslinger, Dr., Alexander (opposition withdrawn)
Merck Sharp & Dohme Corp.
Chiesi Farmaceutici S.p.A. (opposition withdrawn)
Meier, Jürgen - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)European Patent Convention Art 83European Patent Convention R 115(2)Rules of procedure of the Boards of Appeal Art 15(3)
- Keywords
- Sufficiency of disclosure - all claim requests (no)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.